2 completed, 2 recruiting, 1 not yet recruiting. 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 4 | 2 | Recruiting 2 |
Follow Prove pharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients Indigotindisulfonate sodium 0.8% injection - Ureter Injury | Phase 3 | Not yet recruiting | Prove pharm | 18 | 2026-12-01 | 2026-10-16 |
| Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment Saline Injection 0.9%, Indigotindisulfonate sodium 0.8% - Ureter Injury | Phase 4 | Recruiting | Prove pharm | 48 | 2023-12-20 | 2026-01-22 |
| Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency Indigotindisulfonate sodium 0.8%, Saline injection 0.9% - Ureter Injury | Phase 4 | Recruiting | Prove pharm | 116 | 2023-10-12 | 2026-01-22 |
| 3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency 3,3'-Dioxo-2,2'-bisindolylidene-5,5'-disulfonate disodium 0.8%, Saline spray - Ureter Injury | Phase 3 | Completed | Prove pharm | 121 | 2020-02-13 | 2022-11-30 |
| Acquired Methemoglobinemia Observational Registry Methylene Blue - Methemoglobinemia, Acquired, Methemoglobinemia | Completed | Hospital Quality Foundation | 24 | 2018-05-31 | 2023-04-12 |
Indigo Carmine (1) · Injections (1) · Methylene Blue (1)
United States (4)
Michelle Boytim, Ph.D. (2) · Charles V Pollack, MD (1) · Lisa Schwartz (1) · Todd Koch (1)